Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

Ventas Reports Third Quarter Normalized FFO of $0.66 Per Diluted Share

Thu. October 29, 2009; Posted: 06:58 AM
Stocks RSS
CHICAGO, Oct 29, 2009 (BUSINESS WIRE) -- VTR | Quote | Chart | News | PowerRating -- Ventas, Inc. (NYSE: VTR | Quote | Chart | News | PowerRating) ("Ventas" or the "Company") said today that third quarter 2009 normalized Funds From Operations ("FFO") increased 7.4 percent to $103.4 million, from $96.2 million for the comparable 2008 period. Normalized FFO per diluted common share was $0.66 in the third quarter of 2009, compared to $0.68 in the comparable 2008 period. Weighted average diluted shares outstanding in the third quarter of 2009 were 156.5 million, compared to 141.1 million in the comparable 2008 period.

"Ventas's earnings and cash flow this quarter were excellent and benefited from our high-quality, diversified healthcare and seniors housing assets, which continue to perform very well," Ventas Chairman, President and Chief Executive Officer Debra A. Cafaro said. "With low leverage and excess liquidity, we are perfectly positioned to invest when appropriate, and to deliver value to our constituents.

"We are also pleased to increase our 2009 normalized FFO per diluted share guidance," Cafaro added.

Third quarter 2009 normalized FFO per share versus the comparable period in 2008 benefited from rental increases from the Company's triple-net lease portfolio; higher Net Operating Income after management fees ("NOI") at the Company's medical office building ("MOB") operating portfolio; lower interest expense; and lower general, administrative and professional fees, offset by lower NOI at the Company's senior living operating portfolio and higher weighted average diluted shares outstanding.

Normalized FFO for the quarter ended September 30, 2009 excludes the net expense (totaling $5.1 million, or $0.03 per diluted share) from merger-related expenses and deal costs, principally in relation to the Company's favorable verdict in its lawsuit against HCP, Inc. ("HCP"), for which a three-week trial was held during the quarter, offset by income tax benefit; and normalized FFO for the quarter ended September 30, 2008 excluded the net benefit (totaling $16.7 million, or $0.12 per diluted share) from income tax benefit and the reversal of a $23.3 million previously recorded contingent liability, offset by a $6.0 million valuation allowance on real estate mortgage loans receivable, merger-related expenses and deal costs and loss on extinguishment of debt.

FFO, as defined by the National Association of Real Estate Investment Trusts ("NAREIT"), for the third quarter of 2009 decreased 13.0 percent to $98.3 million, from $113.0 million in the prior year. Third quarter 2009 NAREIT FFO per diluted common share decreased 21.3 percent to $0.63, from $0.80 a year earlier due primarily to the reversal of a $23.3 million previously recorded contingent liability, offset by a $6.0 million valuation allowance on real estate mortgage loans receivable recorded during the third quarter of 2008.

Normalized FFO for the nine months ended September 30, 2009 was $304.2 million, or $2.01 per diluted common share, a 6.6 percent increase from $285.5 million, or $2.06 per diluted common share, for the comparable 2008 period. Normalized FFO for the nine months ended September 30, 2009 excludes the net expense (totaling $14.8 million, or $0.10 per diluted share) from merger-related expenses and deal costs and loss on extinguishment of debt, offset by income tax benefit; and normalized FFO for the nine months ended September 30, 2008 excluded the net benefit (totaling $29.3 million, or $0.21 per diluted share) from income taxes and the previously recorded contingent liability reversal, offset by the valuation allowance on real estate mortgage loans receivable and merger-related expenses and deal costs.

SUNRISE PORTFOLIO

Total Portfolio NOI Trending Toward High End of Guidance Range of $122-129 Million

The Company's operating portfolio contains 79 seniors housing communities in North America that are managed by Sunrise Senior Living, Inc. (NYSE: SRZ) ("Sunrise"). Ventas owns 100 percent of 19 of these communities and has a partnership share of between 75 percent and 85 percent in the remaining 60 communities, in which Sunrise owns the noncontrolling interest.

NOI for these 79 communities was $33.4 million for the quarter ended September 30, 2009, compared to $35.2 million for the comparable 2008 period. Year-to-date NOI for the portfolio is $97.7 million.

"We are very pleased that the results from our mansion-style, need-driven seniors housing portfolio managed by Sunrise are trending toward the high end of our NOI guidance range of $122 million to $129 million," said Raymond J. Lewis, Ventas Executive Vice President and Chief Investment Officer. "We continue to support Sunrise management with its efforts to improve occupancy and maintain exceptional standards for our senior residents."

Same-Store Stabilized Community Occupancy Improves Sequentially

For the 78 communities that were stabilized in the second and third quarters of 2009, average occupancy increased to 88.1 percent in the third quarter, versus 87.2 percent in the second quarter. NOI for these 78 communities was $33.0 million in the third quarter of 2009, compared to $33.7 million in the second quarter of 2009. The difference is attributable to 90 basis points of occupancy improvement, offset by higher expenses in the third quarter of 2009.

For the 76 Sunrise communities that were stabilized in the third quarters of both 2009 and 2008, total community NOI was $32.6 million in 2009, versus $34.9 million for the comparable 2008 period.

GAAP NET INCOME

Net income attributable to common stockholders for the quarter ended September 30, 2009 was $49.8 million, or $0.32 per diluted common share, after discontinued operations of $0.1 million, compared with net income attributable to common stockholders for the quarter ended September 30, 2008 of $63.8 million, or $0.45 per diluted common share, after discontinued operations of $1.6 million.

Net income attributable to common stockholders for the nine months ended September 30, 2009 was $212.4 million, or $1.40 per diluted common share, after discontinued operations of $71.4 million, compared with net income attributable to common stockholders for the nine months ended September 30, 2008 of $165.1 million, or $1.19 per diluted common share, after discontinued operations of $32.5 million.

THIRD QUARTER HIGHLIGHTS AND OTHER RECENT DEVELOPMENTS

Portfolio, Performance and Balance Sheet Highlights

Liquidity, Balance Sheet & Credit Ratings

-- In October 2009, Ventas closed $58.4 million of mortgage debt at a blended annual interest rate of 5.5 percent through government-sponsored enterprises.

-- At September 30, 2009, the Company had $9.7 million outstanding under its Revolving Credit Facilities; $853.0 million of undrawn availability; and $126.6 million of cash and short-term cash investments.

-- In October, the Company received indications from two financial institutions that they intend to commit $125 million of additional credit capacity under the Company's Revolving Credit Facilities to mature in 2012. As a result, the Company's Revolving Credit Facilities would expand to $965 million. The first portion of the Revolving Credit Facilities, maturing April 26, 2012, will contain $715 million of borrowing capacity and be priced at LIBOR plus 280 basis points. The second portion of the Revolving Credit Facilities, which matures on April 26, 2010, will contain $250 million of borrowing capacity and be priced at LIBOR plus 75 basis points. There can be no assurance that the Company will receive $125 million of additional credit capacity.

-- At October 28, 2009, the Company had $208.7 million of cash and short-term cash investments.

-- The Company's debt to total capitalization at September 30, 2009 was approximately 30 percent. The Company's net debt to pro forma EBITDA at quarter end was 4.2x.

-- As of October 28, 2009, the Company has $14.6 million in total debt maturities remaining in 2009 and $169.9 million in total debt maturities in 2010, excluding normal periodic principal amortization payments. Additional detail on the Company's debt maturities can be found on the Company's website under the "For Investors" section or at www.ventasreit.com/investors/supplemental.asp.

Investments and Dispositions

-- In August 2009, the Company completed the development and commenced operations of a 75,000 rentable square foot MOB in Parker, Colorado, on the campus of Parker Adventist Hospital. The building was over 80 percent leased at completion, and was delivered on time and on budget.

Portfolio

-- The 197 skilled nursing facilities and hospitals leased by the Company to Kindred Healthcare, Inc. (NYSE: KND) ("Kindred") produced EBITDARM (earnings before interest, taxes, depreciation, amortization, rent and management fees) to actual cash rent coverage of 2.1 times for the trailing twelve-month period ended June 30, 2009 (the latest date available).

Verdict Against HCP

-- On September 4, 2009, the jury unanimously rendered a verdict in favor of Ventas in its lawsuit against HCP, brought in the United States District Court for the Western District of Kentucky (the "Court"), for tortious interference with business expectation arising out of the Company's acquisition of Sunrise Senior Living REIT ("Sunrise REIT") in April 2007. The jury awarded the Company USD $101,672,807 in compensatory damages (100% of the damages the jury was instructed to consider), which represents the difference between the amount the Company would have paid had its Cdn $15 per unit agreement been approved by the Sunrise REIT unitholders and the amount the Company was required to pay to acquire Sunrise REIT, Cdn $16.50 per unit. The jury found that HCP employed "significantly wrongful means," which includes conduct such as fraudulent misrepresentation, deceit and coercion, and "intended" to improperly interfere with the Company's acquisition of Sunrise REIT. On September 8, 2009, the Court entered judgment on the jury's verdict. Both HCP and Ventas have filed post-trial motions that are currently pending before the Court. HCP is required to post security during its post-trial motions and appeal, if any.

Additional Information

-- James L. Andrews recently joined Ventas as Vice President, Hospital Business Development. In this newly created position, Jim will lead the Company's capital deployment efforts with not-for-profit and for-profit hospitals and health systems. Jim previously worked with not-for-profit healthcare systems at, among others, Goldman, Sachs & Co. and Financial Security Assurance (FSA).

-- Beginning in 2009, consistent with U.S. generally accepted accounting principles ("GAAP"), Ventas is recognizing additional non-cash interest expense in connection with the Company's $230 million principal amount of 3 7/8% convertible senior notes due 2011. This non-cash interest expense will decrease 2009 FFO per diluted share by approximately $0.01 per share per quarter. As required by GAAP, this additional non-cash interest expense is reflected in the Company's prior period results, which have been restated for comparability.

-- Supplemental information regarding the Company can be found on the Company's website under the "For Investors" section or at www.ventasreit.com/investors/supplemental.asp.

VENTAS INCREASES GUIDANCE FOR 2009 NORMALIZED FFO PER DILUTED SHARE TO $2.62 TO $2.65

Ventas currently expects its 2009 normalized FFO per diluted share to range between $2.62 and $2.65, improving its previously announced 2009 guidance of between $2.55 and $2.62 per diluted share. Normalized FFO per diluted share in 2008 was $2.71.

The Company's normalized FFO guidance for all periods assumes that all of the Company's tenants and borrowers continue to meet all of their obligations to the Company. In addition, the Company's normalized FFO guidance (and related GAAP earnings projections) excludes (a) gains and losses on the sales of assets, (b) the impact of future unannounced acquisitions or divestitures (including pursuant to tenant options to purchase) and capital transactions, (c) merger-related costs and expenses that are not capitalized under GAAP, including expenses relating to the Company's lawsuit against HCP, (d) net proceeds, if any, the Company may receive from its lawsuit against HCP related to the acquisition of Sunrise REIT, (e) the impact of any expenses related to asset impairment and valuation allowances, the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts or premiums incurred as a result of early retirement or payment of the Company's debt, (f) the non-cash effect of income tax benefits or expenses, (g) deal costs and expenses and earnout payments required by GAAP to be expensed rather than capitalized into asset cost, and (h) the reversal or incurrence of contingent liabilities.

The Company's guidance is based on a number of other assumptions, which are subject to change and many of which are outside the control of the Company. If actual results vary from these assumptions, the Company's expectations may change. There can be no assurance that the Company will achieve these results.

A reconciliation of the Company's guidance to the Company's projected GAAP earnings is provided on a schedule attached to this press release. The Company may from time to time update its publicly announced guidance, but it is not obligated to do so.

THIRD QUARTER CONFERENCE CALL

Ventas will hold a conference call to discuss this earnings release today, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). The dial-in number for the conference call is (617) 614-3523. The participant passcode is "Ventas." The conference call is being webcast live by CCBN and can be accessed at the Company's website at www.ventasreit.com or www.earnings.com. An online replay of the webcast will be available today at approximately 12:00 p.m. Eastern Time and will be archived for one month.

Ventas, Inc., an S&P 500 company, is a leading healthcare real estate investment trust. At the date of this press release, Ventas owns 501 seniors housing and healthcare properties located in 43 states and two Canadian provinces. Its diverse portfolio includes 243 seniors housing communities, 187 skilled nursing facilities, 40 hospitals, and 31 medical office buildings and other properties. More information about Ventas can be found on its website at www.ventasreit.com.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company's or its tenants', operators', managers' or borrowers' expected future financial position, results of operations, cash flows, funds from operations, dividends and dividend plans, financing plans, business strategy, budgets, projected costs, capital expenditures, competitive positions, acquisitions, investment opportunities, merger integration, growth opportunities, dispositions, expected lease income, continued qualification as a real estate investment trust ("REIT"), plans and objectives of management for future operations and statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will" and other similar expressions are forward-looking statements. Such forward-looking statements are inherently uncertain, and security holders must recognize that actual results may differ from the Company's expectations. The Company does not undertake a duty to update such forward-looking statements, which speak only as of the date on which they are made.

The Company's actual future results and trends may differ materially depending on a variety of factors discussed in the Company's filings with the Securities and Exchange Commission. These factors include without limitation: (a) the ability and willingness of the Company's operators, tenants, borrowers, managers and other third parties to meet and/or perform their obligations under their respective contractual arrangements with the Company, including, in some cases, their obligations to indemnify, defend and hold harmless the Company from and against various claims, litigation and liabilities; (b) the ability of the Company's operators, tenants, borrowers and managers to maintain the financial strength and liquidity necessary to satisfy their respective obligations and liabilities to third parties, including without limitation obligations under their existing credit facilities and other indebtedness; (c) the Company's success in implementing its business strategy and the Company's ability to identify, underwrite, finance, consummate and integrate diversifying acquisitions or investments, including those in different asset types and outside the United States; (d) the nature and extent of future competition; (e) the extent of future or pending healthcare reform and regulation, including cost containment measures and changes in reimbursement policies, procedures and rates; (f) increases in the Company's cost of borrowing as a result of changes in interest rates and other factors; (g) the ability of the Company's operators and managers, as applicable, to deliver high quality services, to attract and retain qualified personnel and to attract residents and patients; (h) the results of litigation affecting the Company; (i) changes in general economic conditions and/or economic conditions in the markets in which the Company may, from time to time, compete, and the effect of those changes on the Company's revenues and its ability to access the capital markets or other sources of funds; (j) the Company's ability to pay down, refinance, restructure and/or extend its indebtedness as it becomes due; (k) the Company's ability and willingness to maintain its qualification as a REIT due to economic, market, legal, tax or other considerations; (l) final determination of the Company's taxable net income for the year ending December 31, 2009; (m) the ability and willingness of the Company's tenants to renew their leases with the Company upon expiration of the leases and the Company's ability to reposition its properties on the same or better terms in the event such leases expire and are not renewed by the Company's tenants or in the event the Company exercises its right to replace an existing tenant upon default; (n) risks associated with the Company's senior living operating portfolio, such as factors causing volatility in the Company's operating income and earnings generated by its properties, including without limitation national and regional economic conditions, costs of materials, energy, labor and services, employee benefit costs, insurance costs and professional and general liability claims, and the timely delivery of accurate property-level financial results for those properties; (o) the movement of U.S. and Canadian exchange rates; (p) year-over-year changes in the Consumer Price Index and the effect of those changes on the rent escalators, including the rent escalator for Master Lease 2 with Kindred, and the Company's earnings; (q) the Company's ability and the ability of its operators, tenants, borrowers and managers to obtain and maintain adequate liability and other insurance from reputable and financially stable providers; (r) the impact of increased operating costs and uninsured professional liability claims on the liquidity, financial condition and results of operations of the Company's operators, tenants, borrowers and managers, and the ability of the Company's operators, tenants, borrowers and managers to accurately estimate the magnitude of those claims; (s) the ability and willingness of the lenders under the Company's unsecured revolving credit facilities to fund, in whole or in part, borrowing requests made by the Company from time to time; (t) the impact of market or issuer events on the liquidity or value of the Company's investments in marketable securities; and (u) the impact of any financial, accounting, legal or regulatory issues that may affect the Company's major tenants, operators or managers. Many of these factors are beyond the control of the Company and its management.

CONSOLIDATED FINANCIAL INFORMATION

On January 1, 2009, the Company adopted Financial Accounting Standards Board ("FASB") guidance relating to convertible debt instruments that specifies that issuers of convertible debt instruments that may be settled in cash upon conversion (including partial cash settlement) should separately account for the liability and equity components in a manner that will reflect the entity's nonconvertible debt borrowing rate when interest cost is recognized in subsequent periods. Additionally, on January 1, 2009, the Company adopted FASB guidance which changes the reporting for minority interests, which now must be characterized as noncontrolling interests and classified as a component of consolidated equity. The calculation of income and earnings per share continues to be based on income amounts attributable to the parent and is characterized as net income attributable to common stockholders. As required, all prior period amounts have been restated to reflect the adoption of this new guidance.

CONSOLIDATED BALANCE SHEETS
As of September 30, 2009, June 30, 2009, March 31, 2009, December
31, 2008 and September 30, 2008
(In thousands, except per share amounts)
                                                                    September 30,         June 30,            March 31,           December 31,         September 30,
                                                                    2009                  2009                2009                2008 *               2008 *
Assets
Real estate investments:
Land                                                                $    557,123          $   552,712         $   554,286         $    555,015         $    567,474
Buildings and improvements                                               5,641,309            5,603,042           5,592,051            5,593,024            5,694,198
Construction in progress                                                 8,611                18,319              21,176               12,591               9,533
                                                                         6,207,043            6,174,073           6,167,513            6,160,630            6,271,205
Accumulated depreciation                                                 (1,126,516 )         (1,075,293 )        (1,036,617 )         (987,691  )          (951,523  )
Net real estate property                                                 5,080,527            5,098,780           5,130,896            5,172,939            5,319,682
Loans receivable, net                                                    125,410              125,106             130,076              123,289              113,606
Net real estate investments                                              5,205,937            5,223,886           5,260,972            5,296,228            5,433,288
Cash and cash equivalents                                                70,889               46,523              95,806               176,812              115,923
Escrow deposits and restricted cash                                      96,477               94,470              38,275               55,866               43,841
Deferred financing costs, net                                            27,804               29,569              29,935               22,032               20,833
Notes receivable-related parties                                    -                     -                   -                   -                         1,769
Other                                                                    186,203              176,413             168,858              220,480              200,735
Total assets                                                        $    5,587,310        $   5,570,861       $   5,593,846       $    5,771,418       $    5,816,389
Liabilities and equity
Liabilities:
Senior notes payable and other debt                                 $    2,615,142        $   2,616,304       $   2,942,401       $    3,136,998       $    3,123,815
Deferred revenue                                                         4,628                5,305               6,307                7,057                7,564
Accrued interest                                                         35,481               16,952              42,121               21,931               46,255
Accounts payable and other accrued liabilities                           175,125              164,659             161,775              168,198              152,666
Deferred income taxes                                                    254,622              255,175             255,570              257,499              256,525
Total liabilities                                                        3,084,998            3,058,395           3,408,174            3,591,683            3,586,825
Commitments and contingencies
Equity:
Ventas stockholders' equity:
Preferred stock, $1.00 par value; 10,000 shares authorized,         -                     -                   -                   -                    -
unissued
Common stock, $0.25 par value; 156,605, 156,539, 143,453, 143,302        39,155               39,138              35,867               35,825               35,823
and 143,293 shares issued at September 30, 2009, June 30, 2009,
March 31, 2009, December 31, 2008 and September 30, 2008,
respectively
Capital in excess of par value                                           2,570,146            2,565,933           2,267,440            2,264,125            2,261,874
Accumulated other comprehensive income (loss)                            15,080               (1,411     )        (18,322    )         (21,089   )          4,835
Retained earnings (deficit)                                              (139,478   )         (109,012   )        (117,124   )         (117,806  )          (101,867  )
Treasury stock, 0, 0, 2, 15 and 0 shares at September 30, 2009,          -                    (5         )        (53        )         (457      )          (2        )
June 30, 2009, March 31, 2009, December 31, 2008 and September 30,
2008, respectively
Total Ventas stockholders' equity                                        2,484,903            2,494,643           2,167,808            2,160,598            2,200,663
Noncontrolling interest                                                  17,409               17,823              17,864               19,137               28,901
Total equity                                                             2,502,312            2,512,466           2,185,672            2,179,735            2,229,564
Total liabilities and equity                                        $    5,587,310        $   5,570,861       $   5,593,846       $    5,771,418       $    5,816,389
* Historical financial statements have been restated to reflect
the adoption of FASB guidance relating to the accounting of
convertible debt instruments and FASB guidance relating to
minority interests (now characterized as noncontrolling interests).
CONSOLIDATED STATEMENTS OF INCOME
For the Three and Nine Months Ended September 30, 2009 and 2008
(In thousands, except per share amounts)
                                                                   For the Three Months             For the Nine Months
                                                                   Ended September 30,              Ended September 30,
                                                                   2009          2008 *             2009          2008 *
Revenues:
Rental income                                                      $    126,002  $    121,172       $    374,084  $    358,893
Resident fees and services                                              106,515       108,610            312,853       323,648
Income from loans and investments                                       3,214         3,426              9,828         5,373
Interest and other income                                               99            1,913              493           3,529
Total revenues                                                          235,830       235,121            697,258       691,443
Expenses:
Interest                                                                43,660        50,745             133,942       153,927
Depreciation and amortization                                           50,349        49,997             148,897       176,960
Property-level operating expenses                                       76,338        81,698             224,370       230,497
General, administrative and professional fees (including non-cash       9,657         11,626             30,610        29,493
stock-based compensation expense of $3,078 and $3,326 for the
three months ended 2009 and 2008, respectively, and $9,215 and
$7,816 for the nine months ended 2009 and 2008, respectively)
Foreign currency loss (gain)                                            32            (45     )          31            (151    )
Loss on extinguishment of debt                                          -             344                6,080         460
Merger-related expenses and deal costs                                  5,894         1,248              11,450        3,128
Total expenses                                                          185,930       195,613            555,380       594,314
Income before reversal of contingent liability, income taxes,           49,900        39,508             141,878       97,129
discontinued operations and noncontrolling interest
Reversal of contingent liability                                        -             23,328             -             23,328
Income tax benefit                                                      410           415                1,352         14,165
Income from continuing operations                                       50,310        63,251             143,230       134,622
Discontinued operations                                                 120           1,555              71,352        32,514
Net income                                                              50,430        64,806             214,582       167,136
Net income attributable to noncontrolling interest, net of tax          625           1,040              2,168         2,063
Net income attributable to common stockholders                     $    49,805   $    63,766        $    212,414  $    165,073
Earnings per common share:
Basic:
Income from continuing operations attributable to common           $    0.32     $    0.44          $    0.93     $    0.96
stockholders
Discontinued operations                                                 0.00          0.01               0.47          0.23
Net income attributable to common stockholders                     $    0.32     $    0.45          $    1.40     $    1.19
Diluted:
Income from continuing operations attributable to common           $    0.32     $    0.44          $    0.93     $    0.96
stockholders
Discontinued operations                                                 0.00          0.01               0.47          0.23
Net income attributable to common stockholders                     $    0.32     $    0.45          $    1.40     $    1.19
Weighted average shares used in computing earnings per common
share:
Basic                                                                   156,250       140,759            151,309       138,433
Diluted                                                                 156,516       141,141            151,439       138,859
Dividends declared per common share                                $    0.5125   $    0.5125        $    1.5375   $    1.5375
* Historical financial statements have been restated to reflect
the adoption of FASB guidance relating to the accounting of
convertible debt instruments and FASB guidance relating to
minority interests (now characterized as noncontrolling interests).
QUARTERLY CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
                                                                       2009 Quarters                              2008 Quarters *
                                                                       Third        Second       First            Fourth           Third
Revenues:
Rental income                                                          $   126,002  $   125,148  $   122,934      $   122,735      $   121,172
Resident fees and services                                                 106,515      103,399      102,939          105,609          108,610
Income from loans and investments                                          3,214        3,333        3,281            3,474            3,426
Interest and other income                                                  99           108          286              697              1,913
Total revenues                                                             235,830      231,988      229,440          232,515          235,121
Expenses:
Interest                                                                   43,660       44,171       46,111           50,622           50,745
Depreciation and amortization                                              50,349       48,847       49,701           54,003           49,997
Property-level operating expenses                                          76,338       72,564       75,468           76,447           81,698
General, administrative and professional fees (including non-cash          9,657        10,355       10,598           11,158           11,626
stock-based compensation expense of $3,078, $3,078, $3,059,
$2,160, and $3,326, respectively)
Foreign currency loss (gain)                                               32           5            (6      )        (11     )        (45     )
Loss (gain) on extinguishment of debt                                      -            5,975        105              (2,858  )        344
Merger-related expenses and deal costs                                     5,894        3,502        2,054            1,332            1,248
Total expenses                                                             185,930      185,419      184,031          190,693          195,613
Income before reversal of contingent liability, income taxes,              49,900       46,569       45,409           41,822           39,508
discontinued operations and noncontrolling interest
Reversal of contingent liability                                           -            -            -                -                23,328
Income tax benefit                                                         410          395          547              1,720            415
Income from continuing operations                                          50,310       46,964       45,956           43,542           63,251
Discontinued operations                                                    120          42,219       29,013           14,609           1,555
Net income                                                                 50,430       89,183       74,969           58,151           64,806
Net income attributable to noncontrolling interest, net of tax             625          802          741              621              1,040
Net income attributable to common stockholders                         $   49,805   $   88,381   $   74,228       $   57,530       $   63,766
Earnings per common share:
Basic:
Income from continuing operations attributable to common stockholders  $   0.32     $   0.30     $   0.32         $   0.30         $   0.44
Discontinued operations                                                    0.00         0.27         0.20             0.10             0.01
Net income attributable to common stockholders                         $   0.32     $   0.57     $   0.52         $   0.40         $   0.45
Diluted:
Income from continuing operations attributable to common stockholders  $   0.32     $   0.30     $   0.32         $   0.30         $   0.44
Discontinued operations                                                    0.00         0.27         0.20             0.10             0.01
Net income attributable to common stockholders                         $   0.32     $   0.57     $   0.52         $   0.40         $   0.45
Weighted average shares used in computing earnings per common
share:
Basic                                                                      156,250      154,441      143,091          142,963          140,759
Diluted                                                                    156,516      154,510      143,145          143,047          141,141
Dividends declared per common share                                    $   0.5125   $   0.5125   $   0.5125       $   0.5125       $   0.5125
* Historical financial statements have been restated to reflect
the adoption of FASB guidance relating to the accounting of
convertible debt instruments and FASB guidance relating to
minority interests (now characterized as noncontrolling interests).
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Nine Months Ended September 30, 2009 and 2008
(In thousands)
                                                                     2009                2008 *
Cash flows from operating activities:
Net income                                                           $       214,582     $       167,136
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization (including amounts in discontinued             149,162             180,780
operations)
Amortization of deferred revenue and lease intangibles, net                  (5,151   )          (7,202   )
Other amortization expenses                                                  4,295               3,618
Stock-based compensation                                                     9,215               7,816
Straight-lining of rental income                                             (8,961   )          (11,215  )
Loss (gain) on extinguishment of debt                                        6,080               (63      )
Net gain on sale of real estate assets (including amounts in                 (67,011  )          (25,869  )
discontinued operations)
Income tax benefit                                                           (1,352   )          (14,165  )
Reversal of contingent liability                                             -                   (23,328  )
Provision for loan losses                                                    -                   5,994
Other                                                                        87                  704
Changes in operating assets and liabilities:
Increase in other assets                                                     (4,277   )          (1,294   )
Increase in accrued interest                                                 13,550              25,424
Increase (decrease) in other liabilities                                     12,978              (6,528   )
Net cash provided by operating activities                                    323,197             301,808
Cash flows from investing activities:
Net investment in real estate property                                       (23,728  )          (47,287  )
Investment in loans receivable                                               (7,373   )          (98,826  )
Purchase of marketable debt securities                                       -                   (63,680  )
Proceeds from real estate disposals                                          96,561              58,379
Proceeds from loans receivable                                               7,908               122
Capital expenditures                                                         (7,184   )          (12,174  )
Other                                                                        -                   322
Net cash provided by (used in) investing activities                          66,184              (163,144 )
Cash flows from financing activities:
Net change in borrowings under revolving credit facilities                   (291,456 )          (172,216 )
Proceeds from debt                                                           304,202             10,359
Repayment of debt                                                            (555,290 )          (83,146  )
Payment of deferred financing costs                                          (13,422  )          (655     )
Issuance of common stock, net                                                299,201             408,540
Cash distribution to common stockholders                                     (234,086 )          (215,381 )
Contributions from noncontrolling interest                                   635                 -
Distributions to noncontrolling interest                                     (7,496   )          (5,332   )
Other                                                                        2,003               6,952
Net cash used in financing activities                                        (495,709 )          (50,879  )
Net (decrease) increase in cash and cash equivalents                         (106,328 )          87,785
Effect of foreign currency translation on cash and cash equivalents          405                 (196     )
Cash and cash equivalents at beginning of period                             176,812             28,334
Cash and cash equivalents at end of period                           $       70,889      $       115,923
* Historical financial statements have been restated to reflect
the adoption of FASB guidance relating to the accounting of
convertible debt instruments and FASB guidance relating to
minority interests (now characterized as noncontrolling interests).
QUARTERLY CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
                                                                     2009 Quarters                                        2008 Quarters *
                                                                     Third            Second            First             Fourth            Third
Cash flows from operating activities:
Net income                                                           $   50,430       $   89,183        $   74,969        $   58,151        $   64,806
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization (including amounts in discontinued         50,347           48,907            49,908            54,974            50,969
operations)
Amortization of deferred revenue and lease intangibles, net              (1,564  )        (1,729   )        (1,858   )        (2,142   )        (1,819  )
Other amortization expenses                                              1,921            1,766             608               376               678
Stock-based compensation                                                 3,078            3,078             3,059             2,160             3,326
Straight-lining of rental income                                         (2,971  )        (3,052   )        (2,938   )        (3,437   )        (3,786  )
Loss (gain) on extinguishment of debt                                    -                5,922             158               (105     )        28
Net gain on sale of real estate assets (including amounts in             (120    )        (39,020  )        (27,871  )        (13,157  )        -
discontinued operations)
Income tax benefit                                                       (410    )        (395     )        (547     )        (1,720   )        (415    )
Reversal of contingent liability                                         -                -                 -                 -                 (23,328 )
Provision for loan losses                                                -                -                 -                 -                 5,994
Other                                                                    99               (169     )        157               (90      )        (10     )
Changes in operating assets and liabilities:
(Increase) decrease in other assets                                      (5,703  )        (262     )        1,688             (2,247   )        (7,388  )
Increase (decrease) in accrued interest                                  18,529           (25,169  )        20,190            (24,324  )        25,994
Increase (decrease) in other liabilities                                 14,419           2,526             (3,967   )        9,660             12,997
Net cash provided by operating activities                                128,055          81,586            113,556           78,099            128,046
Cash flows from investing activities:
Net investment in real estate property                                   (4,370  )        (10,971  )        (8,387   )        (6,514   )        (40,927 )
Investment in loans receivable                                           -                -                 (7,373   )        (10,000  )        -
Purchase of marketable debt securities                                   -                -                 -                 -                 (18,900 )
Proceeds from real estate disposals                                      1,188            -                 95,373            45,804            -
Proceeds from loans receivable                                           207              6,051             1,650             13                (166    )
Capital expenditures                                                     (3,156  )        (158     )        (3,870   )        (4,185   )        (7,694  )
Other                                                                    -                -                 -                 1,770             (18     )
Net cash (used in) provided by investing activities                      (6,131  )        (5,078   )        77,393            26,888            (67,705 )
Cash flows from financing activities:
Net change in borrowings under revolving credit facilities               (1,528  )        (202,882 )        (87,046  )        245,582           (88,800 )
Proceeds from debt                                                       3,087            291,914           9,201             129,903           4,005
Repayment of debt                                                        (13,515 )        (428,659 )        (113,116 )        (333,750 )        (30,529 )
Payment of deferred financing costs                                      -                (3,855   )        (9,567   )        (3,202   )        34
Issuance of common stock, net                                            -                299,201           -                 -                 216,872
Cash distribution to common stockholders                                 (80,271 )        (80,269  )        (73,546  )        (73,468  )        (73,499 )
Contributions from noncontrolling interest                               329              306               -                 -                 -
Distributions to noncontrolling interest                                 (2,472  )        (3,610   )        (1,414   )        (10,400  )        (3,396  )
Other                                                                    (3,454  )        1,808             3,649             235               1,695
Net cash (used in) provided by financing activities                      (97,824 )        (126,046 )        (271,839 )        (45,100  )        26,382
Net increase (decrease) in cash and cash equivalents                     24,100           (49,538  )        (80,890  )        59,887            86,723
Effect of foreign currency translation on cash and cash equivalents      266              255               (116     )        1,002             (68     )
Cash and cash equivalents at beginning of period                         46,523           95,806            176,812           115,923           29,268
Cash and cash equivalents at end of period                           $   70,889       $   46,523        $   95,806        $   176,812       $   115,923
* Historical financial statements have been restated to reflect
the adoption of FASB guidance relating to the accounting of
convertible debt instruments and FASB guidance relating to
minority interests (now characterized as noncontrolling interests).
FUNDS FROM OPERATIONS, NORMALIZED FFO AND FUNDS AVAILABLE
FOR DISTRIBUTION
(In thousands, except per share amounts)
                                                              2009 Quarters                  2008 Quarters *
                                                              Third     Second     First     Fourth    Third
Net income attributable to common stockholders                $ 49,805  $ 88,381   $ 74,228  $ 57,530  $ 63,766
Adjustments:
Depreciation and amortization on real estate assets           50,184    48,676     49,531    53,830    49,811
Depreciation on real estate assets related to noncontrolling  (1,580)   (1,496)    (1,620)   (1,582)   (1,590)
interest
Discontinued operations:
Gain on sale of real estate assets                            (120)     (39,020)   (27,871)  (13,157)  -
Depreciation and amortization on real estate assets           -         62         207       971       972
FFO                                                           98,289    96,603     94,475    97,592    112,959
Merger-related expenses and deal costs                        5,894     3,502      2,054     1,332     1,248
Reversal of contingent liability                              -         -          -         -         (23,328)
Provision for loan losses                                     -         -          -         -         5,994
Income tax benefit                                            (797)     (936)      (937)     (2,059)   (982)
Loss (gain) on extinguishment of debt                         -         5,975      105       (2,858)   344
Normalized FFO                                                103,386   105,144    95,697    94,007    96,235
Straight-lining of rental income                              (2,971)   (3,052)    (2,938)   (3,437)   (3,786)
Routine capital expenditures                                  (2,058)   (632)      (1,144)   (3,660)   (2,512)
FAD                                                           $ 98,357  $ 101,460  $ 91,615  $ 86,910  $ 89,937
Per diluted share (1):
Net income attributable to common stockholders                $ 0.32    $ 0.57     $ 0.52    $ 0.40    $ 0.45
Adjustments:
Depreciation and amortization on real estate assets           0.32      0.32       0.35      0.38      0.35
Depreciation on real estate assets related to noncontrolling  (0.01)    (0.01)     (0.01)    (0.01)    (0.01)
interest
Discontinued operations:
Gain on sale of real estate assets                            (0.00)    (0.25)     (0.19)    (0.09)    -
Depreciation and amortization on real estate assets           -         0.00       0.00      0.01      0.01
FFO                                                           0.63      0.63       0.66      0.68      0.80
Merger-related expenses and deal costs                        0.04      0.02       0.01      0.01      0.01
Reversal of contingent liability                              -         -          -         -         (0.16)
Provision for loan losses                                     -         -          -         -         0.04
Income tax benefit                                            (0.01)    (0.01)     (0.01)    (0.01)    (0.01)
Loss (gain) on extinguishment of debt                         -         0.04       0.00      (0.02)    0.00
Normalized FFO                                                0.66      0.68       0.67      0.66      0.68
Straight-lining of rental income                              (0.02)    (0.02)     (0.02)    (0.02)    (0.03)
Routine capital expenditures                                  (0.01)    (0.00)     (0.01)    (0.03)    (0.02)
FAD                                                           $ 0.63    $ 0.66     $ 0.64    $ 0.61    $ 0.64
(1) Per share amounts may not add due to
rounding.
* Historical financial statements have been restated to reflect
the adoption of FASB guidance relating to the accounting of
convertible debt instruments and FASB guidance relating to
minority interests (now characterized as noncontrolling interests).

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen or fallen with market conditions, many industry investors have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. To overcome this problem, the Company considers FFO and FAD appropriate measures of performance of an equity REIT. The Company uses the NAREIT definition of FFO. NAREIT defines FFO as net income, computed in accordance with GAAP, excluding gains (or losses) from sales of property, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect FFO on the same basis. FAD represents normalized FFO excluding straight-line rental adjustments and routine capital expenditures.

FFO and FAD presented herein are not necessarily comparable to FFO and FAD presented by other real estate companies due to the fact that not all real estate companies use the same definitions. Neither FFO nor FAD should be considered as an alternative to net income (determined in accordance with GAAP) as an indicator of the Company's financial performance or as an alternative to cash flow from operating activities (determined in accordance with GAAP) as a measure of the Company's liquidity, nor is FFO or FAD necessarily indicative of sufficient cash flow to fund all of the Company's needs. The Company believes that in order to facilitate a clear understanding of the consolidated historical operating results of the Company, FFO and FAD should be examined in conjunction with net income as presented elsewhere in this press release.

The Company's normalized FFO excludes (a) gains and losses on the sales of assets, (b) merger-related costs and expenses that are not capitalized under GAAP, including expenses relating to the Company's lawsuit against HCP, (c) the impact of any expenses related to asset impairment and valuation allowances, the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts or premiums incurred as a result of early debt retirement or payment of the Company's debt, (d) the non-cash effect of income tax benefits, (e) deal costs and expenses and earnout payments required by GAAP to be expensed rather than capitalized into asset cost beginning in 2009, and (f) the reversal of contingent liabilities.

Normalized FFO and FAD Guidance for the Year Ending December 31, 2009

The following table illustrates the Company's normalized FFO and FAD per diluted common share guidance for the year ending December 31, 2009:

                                                                    UPDATED             PRIOR
                                                                    GUIDANCE            GUIDANCE
                                                                    For the Year        For the Year
                                                                    Ending              Ending
                                                                    December 31, 2009   December 31, 2009
Net income attributable to common stockholders                      $ 1.69 - $ 1.71     $ 1.68 - $ 1.74
Adjustments:
Depreciation and amortization on real estate assets, depreciation   0.82   - 0.82       0.77   - 0.77
related to noncontrolling interest and gain/loss on sale of real
estate assets, net
FFO                                                                 2.51   - 2.53       2.45   - 2.51
Adjustments:
Income tax benefit/expense, gain/loss on extinguishment of debt     0.11   - 0.12       0.10   - 0.11
and merger-related expenses and deal costs, net
Normalized FFO                                                      2.62   - 2.65       2.55   - 2.62
Straight-lining of rental income and routine capital expenditures   (0.13) - (0.13)     (0.13) - (0.13)
FAD                                                                 $ 2.49 - $ 2.52     $ 2.42 - $ 2.49

Net Debt to Pro Forma EBITDA

The following pro forma information considers the effect on net income, interest and depreciation of the Company's investments and other capital transactions that were completed during the three months ended September 30, 2009, as if the transactions had been consummated as of the beginning of the period. The following table illustrates net debt to pro forma earnings before interest, taxes, depreciation and amortization ("EBITDA") (dollars in thousands):

Pro forma net income for the three months ended September 30, 2009 $ 50,511
Add back:
Pro forma interest (including discontinued operations)             43,762
Pro forma depreciation and amortization (including discontinued    50,418
operations)
Stock-based compensation                                           3,078
Income tax benefit                                                 (410)
Noncontrolling interest                                            639
Net gain on real estate disposals                                  (120)
Other taxes                                                        193
Pro forma EBITDA                                                   $ 148,071
Pro forma EBITDA annualized                                        $ 592,284
As of September 30, 2009:
Debt                                                               $ 2,615,142
Cash                                                               (134,056)
Net debt                                                           $ 2,481,086
Net debt to pro forma EBITDA                                       4.2         x

The Company considers EBITDA a profitability measure which indicates the Company's ability to service debt. The Company considers the net debt to pro forma EBITDA ratio a useful measure to evaluate the Company's ability to pay its indebtedness. EBITDA presented herein is not necessarily comparable to EBITDA presented by other companies due to the fact that not all companies

For full details on Ventas (VTR) click here. Ventas (VTR) has Short Term PowerRatings of 6. Details on Ventas (VTR) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [VTR]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.